Semler Scientific Inc (SMLR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Semler Scientific Inc (SMLR) has a cash flow conversion efficiency ratio of -0.072x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-32.95 Million) by net assets ($459.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SMLR equity to assets ratio to measure how much of total assets are equity-financed.
Semler Scientific Inc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Semler Scientific Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Semler Scientific Inc to evaluate the quality of earnings relative to operating cash generation.
Semler Scientific Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Semler Scientific Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alandsbanken Abp A
HE:ALBAV
|
0.054x |
|
Rapac Communication & Infrastructure Ltd
TA:RPAC
|
-0.017x |
|
FibraHotel
MX:FIHO12
|
0.027x |
|
Spear REIT Ltd
JSE:SEA
|
0.045x |
|
ON24 Inc
NYSE:ONTF
|
-0.008x |
|
Guangdong Jinming Machinery Co Ltd
SHE:300281
|
0.013x |
|
EDREAMS ODIGEO UNS.ADR/10
F:K0I
|
0.116x |
|
Jiangsu Jinling Sports Equipment Co Ltd
SHE:300651
|
0.053x |
Annual Cash Flow Conversion Efficiency for Semler Scientific Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of Semler Scientific Inc from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Semler Scientific Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $230.75 Million | $24.41 Million | 0.106x | -57.38% |
| 2023-12-31 | $71.80 Million | $17.82 Million | 0.248x | -20.87% |
| 2022-12-31 | $55.68 Million | $17.46 Million | 0.314x | -11.02% |
| 2021-12-31 | $45.55 Million | $16.06 Million | 0.353x | -30.51% |
| 2020-12-31 | $29.79 Million | $15.11 Million | 0.507x | -47.89% |
| 2019-12-31 | $13.07 Million | $12.73 Million | 0.974x | -13.02% |
| 2018-12-31 | $4.20 Million | $4.70 Million | 1.119x | +565.61% |
| 2017-12-31 | $-2.58 Million | $621.00K | -0.240x | -138.90% |
| 2016-12-31 | $-2.92 Million | $-1.80 Million | 0.618x | -83.98% |
| 2015-12-31 | $-1.07 Million | $-4.13 Million | 3.857x | +446.77% |
| 2014-12-31 | $3.44 Million | $-3.82 Million | -1.112x | -127.53% |
| 2013-12-31 | $-295.00K | $-1.19 Million | 4.041x | +693.27% |
| 2012-12-31 | $-3.58 Million | $-1.82 Million | 0.509x | -81.26% |
| 2011-12-31 | $-469.00K | $-1.27 Million | 2.719x | -- |
About Semler Scientific Inc
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardi… Read more